Zhang Larry 4
4 · CASI Pharmaceuticals, Inc. · Filed Jul 26, 2021
Insider Transaction Report
Form 4
Zhang Larry
President, CASI China
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-07-24−800,000→ 800,000 totalExercise: $1.28Exp: 2031-07-24→ Common Stock (800,000 underlying)
Footnotes (2)
- [F1]The option grant was approved by the Compensation Committee on July 24, 2021. The exercise price per share is the closing market price on July 23, 2021, the last trading day preceding the date of grant.
- [F2]The stock options will vest as follows: 25 percent on each of the first, second, third and fourth anniversaries of the date of grant.